To characterize the individual and combined effects of multimorbidity and functional limitation on healthcare use and mortality in a large, community cohort of individuals with heart failure (HF 
H eart failure (HF) affects more than 6 million individuals in the United States. 1 It is predominantly a disease of elderly adults, so multimorbidity and functional limitation are important concerns. Roughly half of individuals with HF have 5 or more additional chronic conditions. [2] [3] [4] [5] Multimorbidity in individuals with HF has been shown to be associated with worse outcomes, including greater healthcare use and death. [6] [7] [8] Specifically, noncardiovascular (CV) conditions have been shown to be more strongly associated with poor outcomes than CV conditions. 8 Additionally, functional limitation is commonly reported in individuals with HF and has also been shown to be associated with poor outcomes. [9] [10] [11] Although the individual effects of multimorbidity and poor physical functioning on outcomes in individuals with HF have been studied, the combined effect of these conditions on outcomes has not been rigorously evaluated. Emerging evidence suggests that adults with both multimorbidity and functional limitation are high users of health care and incur significant healthcare costs. 12 These individuals had twice the hospital use and visited the doctor more frequently than those with multimorbidity alone, and their annual healthcare expenditures were nearly 3 times as high. 12 We aimed to characterize the individual and combined effects of multimorbidity and functional limitation on healthcare use (including hospitalizations, emergency department (ED) visits, and outpatient visits) and mortality in a large, community cohort of individuals with HF.
METHODS
This study was conducted in southeast Minnesota, in the 11 counties of Dodge, Fillmore, Freeborn, Goodhue, Houston, Mower, Olmsted, Rice, Steele, Wabasha, and Winona, incorporating data from the Mayo Clinic, Mayo Clinic Health System clinics and hospitals, and Olmsted Medical Center and its affiliated clinics. Our study used the Rochester Epidemiology Project (REP), a records linkage system that allows retrieval of nearly all healthcare use and outcomes of residents of southeastern Minnesota. 13, 14 This region has similar age, sex, and ethnic characteristics as the state of Minnesota and the upper midwest region of the United States. 14 
Case Identification
Residents aged 18 and older with a first-ever International Classification of Diseases, Ninth Revision code 428 or Tenth Revision code I50 for HF in the REP records of the 11-county area in southeast Minnesota between January 1, 2013, and March 31, 2016, were identified. These individuals were asked to complete a survey to measure functional status. They were first mailed a survey packet containing the survey, introductory letter, and Health Insurance Portability and Accountability Act form. The survey packet was resent to initial nonresponders approximately 1 month after the first mailing. Finally, a telephone interview was attempted approximately 1 month after the second mailing for the remaining nonresponders.
Multimorbidity and Functional Limitation
Comorbidities were ascertained electronically by retrieving diagnostic codes from inpatient and outpatient encounters at all providers indexed in the REP. We selected comorbidities that the US Department of Health and Human Services has identified for studying multimorbidity: 15, 16 HF, hyperlipidemia, hypertension, arrhythmias, coronary artery disease (CAD), autism, arthritis, asthma, cancer, chronic kidney disease, chronic pulmonary disease, dementia, depression, diabetes, hepatitis, human immunodeficiency virus (HIV), osteoporosis, schizophrenia, substance abuse disorder, and stroke. We excluded HIV (n52) and autism (n50) because of low prevalence and HF because all participants had HF. We added anxiety as an important chronic condition that was not included on the list, resulting in a total of 18 chronic conditions. Two occurrences of a code (the same code or 2 different codes within the code set for a given disease) separated by more than 30 days and occurring within 4 years before the index date were required for diagnosis. Conditions were characterized as CV-related (hyperlipidemia, hypertension, arrhythmias, CAD) and non-CV (all others). Because the majority of participants had multiple CV comorbidities, and non-CV comorbidities are more strongly related to poor outcomes than CV comorbidities, we defined multimorbidity as the presence of 2 or more non-CV comorbidities.
Functional limitation was measured according to activities of daily living (ADLs) and instrumental activities of daily living (IADLs). Participants were asked to selfreport their performance of 8 ADLs and IADLs on a 5-point Likert scale (15without any difficulty to 55 unable to do; score range 8-40; median 8). Patients were asked how much difficulty they had performing the following without assistance: bathing, getting in and out of bed, feeding themselves, dressing, using the toilet, preparing meals, managing medications, and using transportation. Adopting an approach used in previous research, 12 functional limitation was defined as having a score greater than the median (>8), which corresponds to reporting any limitation in at least 1 of the 8 ADLs and IADLs. Participants were categorized into 4 groups according to multimorbidity and functional limitation.
Outcomes
Participants were followed from survey completion through December 31, 2016, for vital status, hospitalizations, ED visits, and outpatient visits. Deaths were identified from medical records and death certificates received from the state of Minnesota. Information on hospitalizations, ED visits, and outpatient visits was collected through the REP, which, as described above, collects information from all in-and outpatient care in the 11 counties. Outpatient visits for tests, imaging, or procedures were not included. ED visits that resulted in a hospitalization were counted as an ED visit and a hospitalization. In-hospital transfers were counted as 1 hospitalization.
Statistical Analysis
Individuals who answered at least 6 of the 8 ADL and IADL questions were retained for analysis. For those who did not answer all the ADL and IADL questions, the mean of the responses was used to replace the missing responses. Baseline characteristics are presented as frequency (percentage) for categorical variables, mean6standard deviation for normally distributed continuous variables, and median (interquartile range) for continuous variables with a skewed distribution. Chi-square tests for categorical variables and analysis of variance for continuous variables were used to test trends in characteristics in the 4 multimorbidity and functional limitation groups.
Cox proportional hazards regression was used to examine the association between the groups and death. Models were run unadjusted and then controlling for age, sex, education, and marital status. To account for repeated events, associations between groups and all-cause outpatient visits, ED visits, and hospitalizations were analyzed using Andersen-Gill models univariately and adjusted as for death. Pairwise comparisons of the 4 groups were tested controlling for the false discovery rate to account for multiple comparisons. 17 The proportional hazard assumption was tested using the scaled Schoenfeld residuals and found to be valid.
All analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC). The Mayo Clinic and Olmsted Medical Center institutional review boards approved this study.
RESULTS
Of 6,346 individuals with HF who were mailed a survey, 803 were excluded (deceased (n5270), lost to follow-up (n523), physically or mentally unable (n5447), and language barrier (n563)), resulting in 5,543 individuals, 2,866 of whom returned the survey (response rate 52%). Survey respondents were slightly older (72.4 vs 71.2; p5.002) than nonrespondents but had a similar sex distribution (p5.90).
Individuals with incomplete survey data (n553, 2%) and those who returned their surveys after December 31, 2016 (n5121, 4%) were excluded from the analysis, resulting in the sample size of 2,692 (mean age 73.6, 53.7% male) ( Table 1) . Six hundred seventy-four (25%) participants had neither multimorbidity nor functional limitation, 932 (35%) had multimorbidity only, 248 (9%) had functional limitation only, and 838 (31%) had multimorbidity and functional limitation. The most common non-CV related conditions were diabetes (45%), arthritis (40%), and cancer (31%). Of the 8 ADLs and IADLs measured, participants most frequently reported that they had much difficulty with or were unable to use transportation (37%), prepare meals (28%), and bathe (23%) on their own.
After a mean6SD follow-up of 14.667.8 months, 249 deaths had occurred. Mortality in the groups with both multimorbidity and functional limitation and only functional limitation were significantly greater than in the other groups (Figure 1 , p<.001). After adjustment for age, sex, education, and marital status, participants with both multimorbidity and functional limitation (HR54.92, 95% CI53.03-8.00; Table 2 ) and those with functional limitation alone (HR 4.84, 95% CI52.78-8.43) were almost 5 times as likely to have died as those with neither. Participants with multimorbidity alone were 72% more likely to have died (HR51.72, 95% CI51.01-2.92). Testing the pairwise comparisons of the 4 groups while controlling for the false discovery rate resulted in statistically significant Table 2) . Those with multimorbidity alone had risks of ED visits and hospitalizations similar to those of participants with functional limitation alone, although they were 50% more likely to have an outpatient visit (HR51.50, 95% CI51.34-1.67) ( Table 2 ). Testing the pairwise comparisons among the 4 groups while controlling for the false discovery rate resulted in statistically significant differences between all pairs for outpatient visits except for those with functional limitation only versus those with neither multimorbidity nor functional limitation. For ED visits and hospitalizations, all comparisons were significantly different except for multimorbidity alone versus functional limitation alone.
In ancillary analyses in which functional limitation was defined using only ADLs, similar results were obtained when analyzing the associations between the multimorbidity and functional limitation groups and outcomes, although the associations were slightly attenuated for death, hospitalizations, and ED visits.
DISCUSSION
In our large, contemporary cohort of individuals with HF, 31% had multimorbidity and functional limitation, 35%
had multimorbidity alone, 9% had functional limitation alone, and 25% had neither. Individuals with both multimorbidity and functional limitation had the highest risk of death, hospitalization, ED visits, and outpatient visits. The risk of death for those with functional limitation only was comparable with that of those with multimorbidity and functional limitation and higher than that of those with multimorbidity alone. In addition, their risk of hospitalizations and ED visits was comparable with that of those with multimorbidity only. Finally, the risk of outpatient visits for those with multimorbidity only was higher than that of those with functional limitation only. These results have important implications for targeting interventions to those most likely to benefit. The individual effects of multimorbidity have been studied in individuals with HF. We previously studied a community cohort of individuals with HF and found that, on average, they have 4 additional comorbid conditions. 8 Furthermore, although the most common comorbidities were CV in nature, the burden of other physical and mental conditions was more strongly associated with death and hospitalizations. A study of Medicare beneficiaries with HF found that number of comorbidities was associated with mortality and that several noncardiac conditions were associated with death. 3 Another study of Medicare beneficiaries reported that nearly 40% of individuals with HF have 5 or more noncardiac conditions and that the risk of hospitalization increased with increasing number of these conditions. 6 Functional limitation has also been found to be associated with adverse outcomes in individuals with HF. We previously found that more than half of individuals with HF report difficulty with one or more ADLs and that greater ADL difficulty was associated with greater mortality. 9 ADL difficulty was also associated with greater risk of hospitalization. In a study of individuals with HF from the Cardiovascular Health Study, IADLs were associated with mortality, whereas other measures of functional impairments, including ADLs and 15-foot walk time were not.
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The combined effects of multimorbidity and functional limitation on outcomes in individuals with HF are less well known. In our large, community cohort of individuals with HF, 31% had multimorbidity and functional limitation. These individuals were at the greatest risk of death, hospitalization, ED visits, and outpatient visits. Our results augment a recent analysis of data from the 2009-11 Medical Expenditure Panel Survey, which found that adults aged 18 and older with multimorbidity (3 chronic conditions) and functional limitation (self-reported limitation in an ADL or IADL) had annual healthcare expenditures that were nearly 3 times as high as expenditures of those with multimorbidity alone. 12 Rates of hospital use were twice as high, and doctor visits were more frequent for individuals with both multimorbidity and functional limitation than for those with multimorbidity alone. 12 In a recent study of the Health and Retirement Study, participants were classified into 4 groups: having 1 or more severe medical conditions or receiving assistance with ADLs (functional limitation), having a hospital admission in the last 12 months or residing in a nursing home plus 1 or more conditions or functional limitations, having a hospital admission in the last 12 months or residing in a nursing home plus a condition and functional limitation, meeting none of the above criteria. 18 Patients in the third group had the highest proportion of hospitalizations, total Medicare expenditures, and mortality after 1 year. 18 We found that individuals with multimorbidity or functional limitation alone had similar risk of hospitalizations and ED visits. This is important because it provides further evidence that multimorbidity and functional limitation should both be considered when managing individuals with HF. Another interesting finding was that having functional limitation only was associated with a much greater risk of death but that having multimorbidity only was not, which underscores the importance of functional limitation in the prognosis of individuals with HF.
Clinical Implications
This work has important clinical implications because we expand upon previous work by studying not only the individual effects but also the combined effects of multimorbidity and functional limitations on outcomes in HF. Our results indicate that multimorbidity and functional limitation are common in individuals with HF and have important prognostic value. Individuals with both multimorbidity and functional limitation have the highest risk of death and healthcare use. Thus, interventions should be targeted to these people to improve their outcomes. Interventions to improve physical functioning appear to be effective in individuals with HF, [19] [20] [21] and the importance of recognizing the complexity of caring for individuals with multiple chronic conditions has been recently highlighted, 22 as has incorporating principles of geriatrics into the care of individuals with CV disease. 23 Having multiple conditions increases the challenges for healthcare providers and individuals and can affect safety if recommendations for one condition conflict with those of another. 22 Thus these complex individuals should be the target of future interventions to undercover ways to best manage them and improve their outcomes.
Limitations and Strengths
Some limitations to the study should be noted. As in any survey study, nonresponder bias could be a weakness, although baseline characteristics were similar between those who completed the survey and those who did not. We may have missed some healthcare encounters that occurred outside of the 11-county REP area. Our study was conducted in a mostly white population, so generalizability may be limited, although a prior epidemiological study demonstrated that the population from which our cohort was derived is similar to the population of the upper Midwest in terms of age, sex, and ethnic characteristics. 24 Our study also has notable strengths. It was a large, community-based cohort study, and we had comprehensive ascertainment of comorbidities, death, and healthcare use in a large area of southeast Minnesota. 13 This was 1 of the first studies to report on the combined effects of multimorbidity and functional limitation in individuals with HF. Furthermore, our response rate was somewhat higher than response rates in national surveys. 25 
CONCLUSIONS
Individuals with both multimorbidity and functional limitation have the highest risk of death and healthcare use. Individuals with functional limitation alone have similar rates of hospitalization and ED visits but greater risk of death than those with multimorbidity alone. This underscores the need to consider multimorbidity and functional limitation when managing individuals with HF.
